Yahoo Finance4d
Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting
MINNEAPOLIS, March 24, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced further advancements in its ongoing strategy to bring translational discoveries to patient care by ...
Seeking Alpha29d
Bio-Techne: Attractive Markets And A Good Moat, But Valuation Is Seldom A Bargain
Bio-Techne's shares have been pressured lately on concerns about the academic research market and biopharma R&D restructuring, but core business trends look largely intact. Fiscal Q2 showed ...
Benzinga.com10d
6 Analysts Assess Bio-Techne: What You Need To Know
In the preceding three months, 6 analysts have released ratings for Bio-Techne TECH, presenting a wide array of perspectives from bullish to bearish. The following table encapsulates their recent ...
Business Insider10d
Bio-Techne initiated with an Outperform at Evercore ISI
Evercore ISI initiated coverage of Bio-Techne (TECH) with an Outperform rating and $75 price target The firm believes that current volatility creates a “nice entry point” for Bio-Techne as ...
The Mercury29d
Techne Invest office tower development at former site of Spotlight store hits snag
A 12-storey office tower development backed by AFL legend Nick Riewoldt has encountered an obstacle, with construction no longer set to go ahead this month as originally planned. The $40m tower ...
Fidelity International3d
Bio-Techne Corp (TECH)
Bio-Techne Corp and is a biotechnology company which develops, manufactures and sells biotechnology reagents, instruments and clinical diagnostic products.